D-0441-2026 Class II Ongoing
FDA drug recall D-0441-2026 was initiated by Fagron Compounding Services on Mar 20, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port The recall status is ongoing. Affected quantity: 16,130 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 15, 2026
- Initiation Date
- Mar 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,130 bags
Product description
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01
Reason for recall
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Distribution pattern
Nationwide in the U.S.A.
Code information
Lot: C274-000050858, Exp.:7/6/2026; C274-000051018, Exp.: 7/13/2026; C274-000049194, Exp.: 4/20/2026; C274-000049591, Exp.: 5/9/2026; C274-000049592, Exp.: 5/9/2026; C274-000049823, Exp.: 5/18/2026; C274-000050301, Exp.: 6/8/2026; C274-000050411, Exp.: 6/13/2026; C274-000051056, Exp.:7/18/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0441-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026